3 results  1 of 1 

1 Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
Yujin Jin, Kyung-Sun Heo
Korean J Physiol Pharmacol.2023;27(4):299-310.   Published online 2023 July 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.4.299
      
2 IDH1/2 mutations in acute myeloid leukemia
Ja Min Byun, Seung-Joo Yoo, Hyeong-Joon Kim, Jae-Sook Ahn, Youngil Koh, Jun Ho Jang, Sung-Soo Yoon
Blood Res.2022;57(1):13-19.   Published online 2022 March 31     DOI: http://dx.doi.org/10.5045/br.2021.2021152
      
3 In silico analysis of putative drug and vaccine targets of the metabolic pathways of Actinobacillus pleuropneumoniae using a subtractive/comparative genomics approach
Biruk T. Birhanu, Seung-Jin Lee, Na-Hye Park, Ju-Beom Song, Seung-Chun Park
J Vet Sci.2018;19(2):188-199.   Published online 2018 March 23     DOI: http://dx.doi.org/10.4142/jvs.2018.19.2.188
      

 1 of 1